Publication: The regulation mechanism of apoptosis by visfatin in the mesenteric lymph nodes of LPS-treated rats
Authors
Xiao, Ke ; Zhou, Ying ; Yuan, Huai Rui ; Cui, Lu ; Rehman, Zia ur ; Ansari, Abdur Rahman ; Yang, Zhi ; Peng, Ke Mei ; Song, Hui
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de BiologĂa Celular e HistologĂa
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-731
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Visfatin is an adipocytokine displaying
multiple functional properties, which plays a role in the
regulation of cell apoptosis and inflammation by an as
yet unidentified mechanism. The aim of the present
study was to determine if visfatin is involved in
apoptosis pathway induced by LPS in rat Mesenteric
lymph nodes (MLNs). Experimental rats were divided
into four groups and MLNs samples were collected from
each group. The morphological changes of the MLNs
were examined by histological imaging. CD68 and
ENPP1 were detected with immunohistochemistry and
Western Blot. Apoptosis was evaluated with TUNEL and
Flow Cytometry, the mRNA levels of the apoptosisrelated genes were detected by qRT-PCR, and the protein
levels of the apoptotic-related factors were detected by
western blot. The main results showed that visfatin could
significantly increase the macrophages in MLNs and
prevent cell apoptosis from LPS-induced mesenteric
lymph nodes, activate apoptotic signaling pathways and
regulate the mRNA levels of the apoptosis-related genes.
Visfatin had a pro-apoptotic effect on normal MLNs,
whereas it exerted an anti-apoptotic effect during LPSinduced cell apoptosis in rat MLNs. In short, visfatin
plays a dual role in the apoptosis in rat MLNs, which is
mediated by both the mitochondrial apoptotic pathway
and the death-receptor apoptotic pathway.
publication.page.subject
Citation
Histology and Histopathology, Vol.31, nÂş9, (2016)
item.page.embargo
Ir a EstadĂsticas
Este Ătem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/